Cantitate/Preț
Produs

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Autor Manorama Bhargava
en Limba Engleză Paperback – 15 feb 2022
This book is a compendium of case studies in hematologic malignancies such as acute leukemias, myelodysplastic and myeloproliferative neoplasms, chronic leukemias and multiple myeloma covering cytogenetics (karyotyping Fluorescence in sitn hybridization (FISH)) and molecular studies in detail.  The first few chapters describe the methodology employed for karyotyping, FISH and Real Time PCR technology conducive to establishment of these labs if required. Each case study is described in detail by including the clinical history of the patient, findings of peripheral blood, bone marrow aspirate and bone biopsy morphological details. This is then followed by flowcytometric immunophenotyping, cytogenetic and molecular observations leading collectively to a final diagnosis, A discussion follows based on the relevance of this data in informing the prognosis, treatment response and survival in these patients. Additionally, this data serves as a key determinant for clinical decision making involving evidence based rational management of patients including targeted therapy. For better understanding, each case study is accompanied by black and white or colour images as appropriate. This book is a source of learning and a valuable read for clinical hematologists, hematopathologists, medical oncologists, residents, interns, DM Hematology students and DNB Hematology students as well.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 105979 lei  38-44 zile
  Springer Nature Singapore – 15 feb 2022 105979 lei  38-44 zile
Hardback (1) 107010 lei  38-44 zile
  Springer Nature Singapore – 14 feb 2021 107010 lei  38-44 zile

Preț: 105979 lei

Preț vechi: 111556 lei
-5% Nou

Puncte Express: 1590

Preț estimativ în valută:
20282 21395$ 16951£

Carte tipărită la comandă

Livrare economică 27 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789813348011
ISBN-10: 9813348011
Pagini: 246
Ilustrații: XXVI, 246 p. 232 illus., 114 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.64 kg
Ediția:1st ed. 2021
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore

Cuprins

Section I    Cytogenetic 
Chapter 1: Techniques in cytoenetics (Karotyping and FISH)
Chapter 2:Case studies in Acute Myeloid Leukemia
Chapter 3:Case studies in Acute Lymphoblastic leukemia
Chapter 4:Case studies in Chronic Myeloid Leukemia
Chapter 5:Case studies in Myelodys Plastic Syndrome
Chapter 6:Case studies on FISH in Chronic Lymphocytic Leukemia
Chapter 7:Case studies on FISH in Multiple Myeloma
Section II Molecular Hematology
Chapter 1: Techniques in Molecular Hematology 
Chapter 2:Case studies in Chronic Myeloid Leukemia
Chapter 3:Case studies in Acute Myeloid Leukemia
Chapter 4:Case studies in Acute Lymphoblastic leukemia)
Chapter 5:Case studies in Myeloproliferative Neoplasms


Recenzii




Notă biografică

Dr. Bhargava has served as a Professor and Head, Department of Hematology at the prestigious All India Institute of Medical Sciences until September 2001, Sir Ganga Ram Hospital till 2016 and as Senior Advisor and Head Hematopathology at Medanta, The Medicity until May 2020.
Dr. Bhargava is a pioneer in Hematology in India and is widely recognised for her contributions to Hematology both nationally and internationally.  In a career spanning almost 50 years, she advocated and brought awareness for hematology as a discipline separate from Internal Medicine and Pathology where it constituted a minor part.  Recipient of prestigious fellowships such as Alexander Von Humboldt, Fogarty and INSA fellowships. She has been principal investigator on several research grants, notably Indo-US, Indo-French, Indo–German and Indo-Japan grants and has published more than 300 articles in national and international journals.
In recognition of her contributions to Hematology, she was awarded the Dr. B.C. Roy National Award and the highest award of Indian Council of Medical Research, the Basanti Devi Amirchand prize. An acclaimed teacher, she established the first  ever superspecialty degrees of DM in clinical Hematology and DM in Hematapathology in the year 2000 at the All India Institute of Medical Sciences and the Diplomate National Board in Hematology in 2008.

Textul de pe ultima copertă

This book is a compendium of case studies in hematologic malignancies such as acute leukemias, myelodysplastic and myeloproliferative neoplasms, chronic leukemias and multiple myeloma covering cytogenetics (karyotyping Fluorescence in sitn hybridization (FISH)) and molecular studies in detail.  The first few chapters describe the methodology employed for karyotyping, FISH and Real Time PCR technology conducive to establishment of these labs if required. Each case study is described in detail by including the clinical history of the patient, findings of peripheral blood, bone marrow aspirate and bone biopsy morphological details. This is then followed by flowcytometric immunophenotyping, cytogenetic and molecular observations leading collectively to a final diagnosis, A discussion follows based on the relevance of this data in informing the prognosis, treatment response and survival in these patients. Additionally, this data serves as a key determinant for clinical decision making involving evidence based rational management of patients including targeted therapy. For better understanding, each case study is accompanied by black and white or colour images as appropriate. This book is a source of learning and a valuable read for clinical hematologists, hematopathologists, medical oncologists, residents, interns, DM Hematology students and DNB Hematology students as well.

Caracteristici

Explains the significance of the results obtained towards the prognosis and treatment response
Presents several case studies in hematologic malignancies with particular reference to cytogenetics
Describes a vision of future development towards enhancing diagnosis and application of targeted therapies